Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

23.34
-1.9400-7.67%
Post-market: 23.600.2600+1.11%19:37 EDT
Volume:2.00M
Turnover:47.46M
Market Cap:3.94B
PE:-27.79
High:25.09
Open:24.93
Low:23.28
Close:25.28
52wk High:34.39
52wk Low:6.25
Shares:169.00M
Float Shares:142.96M
Volume Ratio:0.83
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8400
EPS(LYR):-0.8746
ROE:-21.34%
ROA:-12.99%
PB:3.85
PE(LYR):-26.69

Loading ...

Tango Therapeutics (TNGX) Is Getting Fresh Attention, What Are Investors Looking At?

Simply Wall St.
·
Aug 14

Tango Therapeutics Ajukan Program Penjualan Saham At-the-Market Hingga USD 400 Juta

Reuters
·
Aug 12

Tango Therapeutics - Files Prospectus to Sell up to $400 Mln in Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 12

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

Tango Therapeutics Q2 Net Loss Widens to $55.3 Million; G&A Expenses Climb 99% to $22.6 Million

Reuters
·
Aug 11

Earnings Flash (TNGX) Tango Therapeutics Posts Q2 Loss $0.37 a Share, vs. FactSet Est of $0.32 Loss

MT Newswires Live
·
Aug 11

Tango Therapeutics Q2 Net Income USD -55.341 Million

THOMSON REUTERS
·
Aug 11

Tango Therapeutics Q2 Basic EPS USD -0.37

THOMSON REUTERS
·
Aug 11

Press Release: Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Dow Jones
·
Aug 11

U.S. Earnings Preview: Before Market Open Aug. 11

Dow Jones
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Tango Therapeutics Files Amended 8-K on Executive Chair Transition

Reuters
·
Aug 07

Tango Therapeutics executive chairman Weber to step down

TIPRANKS
·
Aug 07

Tango Therapeutics Executive Chair Barbara Weber Steps Down, Exits Board

Reuters
·
Aug 07

Tango Therapeutics Announces Executive Chair Transition

THOMSON REUTERS
·
Aug 07

Tango Therapeutics - Barbara Weber's Employment as Executive Chair Ended on August 3, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 07

Tango Therapeutics President, R&D Crystal Adam Disposes of USD 734,514 Common Shares

Reuters
·
Aug 06

Mizuho Securities Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)

TIPRANKS
·
Jul 19

Movement Alert|Tango Therapeutics Falls 8.44% in Regular Trading, Trading at $28.56

Market Focus
·
Jul 14